Metabolic therapeutics therapeutics Market Research Reports

"...... ipidemia is defined as elevation of the total cholesterol, the "bad" low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the "good" high-density lipoprotein (HDL) cholesterol concentration in the blood. Nu......"

"...... scape. Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity, hypertension, high lipi......"

"...... l accumulation of amyloid protein in the tissues results in a group of diseases known as amyloidosis. It may affect the shape and functioning of the organ eventually leading to organ failure. Predisposing factors are misfolding of abnormal protein ca......"

"...... e landscape. Diabetic macular edema (DME) occurs when blood vessels in the retina of patients with diabetes begin to leak into the macula, the part of the eye responsible for detailed central vision. Common symptoms of DME are blurry vis......"

"...... bolic Disorders) pipeline landscape. "Diabetic neuropathy is nerve damage caused by diabetes. The type of neuropathy occurring in the arms, hands, legsand feet is known as diabetic peripheral neuropathy. Symptoms include numbness or ting......"

"...... glycemia is a condition characterized by an abnormally low level of blood sugar (glucose). Symptoms of hypoglycemia include tachycardia, anxiety, shaking, and irritability, feelings of hunger, weakness, tiredness, dizziness, headache, confusion, and ......"

"...... Insulin resistance (IR) is a condition in which the body's cells become resistant to the effects of insulin. This occurs when insulin levels are sufficiently high over a prolonged period of time causing the body's own sensitivity to the......"

"...... andscape. Phenylketonuria (also called PKU), is a rare inherited disorder that causes an amino acid called phenylalanine to build up in body. Symptoms include intellectual disability, psychiatric disorders, hyperactivity, skin rashes, po......"

"...... s in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The HET Obesity/POMC Deficiency Obesity market report provides current treatment practices, emerging drugs, HET Obesity/POMC Deficiency Obesity market s......"

"...... France, and United Kingdom) and Japan. The Metabolic Acidosis market report provides current treatment practices, emerging drugs, Metabolic Acidosis market share of the individual therapies, current and forecasted Metabolic Acidosis market Si......"